PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Entitlement Offer and Placement Prospectus, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    In all fairness do you not think it is better to vote yes given that this is based on future performance metrics? Shouldn't we be providing an incentive for PR and DS to achieve the stated objectives? As you would know I've been very critical of PR, but I think voting no will be a mistake given the next 12 months will be vital to PAR's success.
    Last edited by Zenox: 30/10/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.